BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III Melanoma  Graham.

Slides:



Advertisements
Similar presentations
Telomerase Activity and Expression of Telomerase RNA Component and Telomerase Catalytic Subunit Gene in Cervical Cancer Kenji Nakano, Elizabeth Watney,
Advertisements

Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar The.
Francesca Capon  Journal of Investigative Dermatology 
Genetic Profiling of BRAF Inhibitor–Induced Keratoacanthomas Reveals No Induction of MAP Kinase Pathway Expression  Rajan P. Kulkarni, Seema Plaisier,
Chunying Li, Ming Yin, Li-E Wang, Christopher I
Next-Generation Sequencing: Methodology and Application
Dacarbazine Promotes Stromal Remodeling and Lymphocyte Infiltration in Cutaneous Melanoma Lesions  Alessandra Nardin, Wing-Cheong Wong, Charlene Tow,
Microarray Technique, Analysis, and Applications in Dermatology
Correction to: “Journal of Investigative Dermatology” advance online publication, 9 April 2015; doi: /jid   Emilie S. Chan, Leal C. Herlitz,
A New View of Vitiligo: Looking at Normal-Appearing Skin
Matthew O. Ivory, James C. Birchall, Vincent Piguet 
PHIPing Out: A Genetic Basis for Tumor Ulceration
Comparative Effectiveness Research
Clinical Snippets Journal of Investigative Dermatology
Socioeconomic Patterning in the Incidence and Survival of Children and Young People Diagnosed with Malignant Melanoma in Northern England  Richard J.Q.
Identification, Review, and Systematic Cross-Validation of microRNA Prognostic Signatures in Metastatic Melanoma  Kaushala Jayawardana, Sarah-Jane Schramm,
Leon Raskin, Douglas R. Fullen, Thomas J. Giordano, Dafydd G
Kavitha K. Reddy  Journal of Investigative Dermatology 
Databases for Clinical Research
Circulating Tumor Cells and Melanoma Progression
Photosensitizing Agents and the Risk of Non-Melanoma Skin Cancer: A Population- Based Case–Control Study  Zaineb H. Makhzoumi, Sarah T. Arron  Journal.
Multivariable Analysis
Sarah-Jane Schramm, Anna E. Campain, Ricenterd A
Meeting Report from Frontiers in Ichthyosis Research
The Thinning Top: Why Old People Have Less Hair
Alice Pentland  Journal of Investigative Dermatology 
Clinical Snippets Journal of Investigative Dermatology
Minutes of the Board of Directors Meeting
Selective Loss of Wild-Type p16INK4a Expression in Human Nevi
Mizuho Fukunaga-Kalabis, Meenhard Herlyn 
Unraveling the Mysteries of IGF-1 Signaling in Melanoma
Star Trek Publishing Journal of Investigative Dermatology
KIT in Melanoma: Many Shades of Gray
Psoriasis May Not be an Independent Risk Factor for Acute Ischemic Heart Disease Hospitalizations: Results of a Large Population-Based Dutch Cohort  Marlies.
Journal of Investigative Dermatology
Journal of Investigative Dermatology 
CXCR4 in Epidermal Keratinocytes: Crosstalk within the Skin
Society for Investigative Dermatology 2010 Meeting Minutes
Journal of Investigative Dermatology
Democratizing the Clinical Trials Agenda in Dermatology
Maria T. García-Romero, Roberto Arenas 
BJD Editor's Choice Journal of Investigative Dermatology
BRAF and NRAS Mutations Are Frequent in Nodular Melanoma but Are not Associated with Tumor Cell Proliferation or Patient Survival  Lars A. Akslen, Sabrina.
Cells of Origin in Skin Cancer
Research Snippets Journal of Investigative Dermatology
Clinical Snippets Journal of Investigative Dermatology
Journal of Investigative Dermatology
How Much Sun Protection Is Needed
Genetic Influences on Human Body Odor: From Genes to the Axillae
Katie Ridd, Siegrid Yu, Boris C. Bastian 
Interpretation of Skindex-29 Scores
Metabolic Vulnerability in Melanoma: A ME2 (Me Too) Story
Research Snippets from the British Journal of Dermatology
Melanocyte Regeneration in Vitiligo Requires WNT beneath their Wings
TLR3: A Receptor that Recognizes Cell Injury Is Essential for Permeability Barrier Homeostasis Following UV Irradiation  Kenneth R. Feingold  Journal.
AIM1 and LINE-1 Epigenetic Aberrations in Tumor and Serum Relate to Melanoma Progression and Disease Outcome  Sojun Hoshimoto, Christine T. Kuo, Kelly.
25 Years of Epidermal Stem Cell Research
Journal of Investigative Dermatology
Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma.
Research Snippets Journal of Investigative Dermatology
Journal of Investigative Dermatology
Consequences of Psychological Distress in Adolescents with Acne
Journal of Investigative Dermatology
Journal of Investigative Dermatology
Activation of B-raf in Non-Malignant Nevi Predicts a Novel Tumor Suppressor Gene in Melanoma (MAP Kinase Phosphatase)  Jack L. Arbiser  Journal of Investigative.
Journal of Investigative Dermatology
Wedge Resection for Non-small Cell Lung Cancer in Patients with Pulmonary Insufficiency: Prospective Ten-Year Survival  John P. Griffin, MD, Charles E.
Prediction in idiopathic membranous nephropathy
Innate Immunity Stimulates Permeability Barrier Homeostasis
Comparison of tumor staging systems for cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia  Jacob J. Inda, MD, Brian F. Kabat,
Presentation transcript:

BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III Melanoma  Graham J. Mann, Gulietta M. Pupo, Anna E. Campain, Candace D. Carter, Sarah-Jane Schramm, Svetlana Pianova, Sebastien K. Gerega, Chitra De Silva, Kenneth Lai, James S. Wilmott, Maria Synnott, Peter Hersey, Richard F. Kefford, John F. Thompson, Yee Hwa Yang, Richard A. Scolyer  Journal of Investigative Dermatology  Volume 133, Issue 2, Pages 509-517 (February 2013) DOI: 10.1038/jid.2012.283 Copyright © 2013 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 1 Factors independently associated with melanoma-specific survival >4 years on multivariable logistic regression analysis. (a) Model incorporating clinico-pathologic variables* alone; (b) model incorporating clinico-pathologic variables and signature of differentially expressed genes (according to Tibshirani and Efron (2002)). *Stage II or stage III at presentation; the presence of nodular histological component; large cell size; increased pigmentation; the presence of activating BRAF or NRAS mutation. Journal of Investigative Dermatology 2013 133, 509-517DOI: (10.1038/jid.2012.283) Copyright © 2013 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 2 Supervised hierarchical clustering gene expression based on the 60-probe (46 gene) signature with strongest association with prognosis in 48 American Joint Committee on Cancer (AJCC) stage III melanoma patients. Journal of Investigative Dermatology 2013 133, 509-517DOI: (10.1038/jid.2012.283) Copyright © 2013 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 3 Melanoma-specific survival in 79 American Joint Committee on Cancer (AJCC) stage III patients according to the presence or absence of a favorable 60-probe (46 gene) signature. KM, Kaplan–Meier. Journal of Investigative Dermatology 2013 133, 509-517DOI: (10.1038/jid.2012.283) Copyright © 2013 The Society for Investigative Dermatology, Inc Terms and Conditions